MAI Capital Management
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1040197
INDEPENDENCE, OH
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,187,071
-$724,601 QoQ
Shares Held
6,715
+5.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#411
of 1,322 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MAI Capital Management holds $23,665,100 across 54 Biotechnology names. REGN ranks #1 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
6,715 | $4,187,071 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,638 | $2,800,563 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
49,160 | $1,264,394 | |
| 4 | INCY |
Incyte Corp
|
10,126 | $1,147,882 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
|
56,130 | $1,046,824 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
5,147 | $963,929 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
2,963 | $936,574 | |
| 8 | EXEL |
Exelixis, Inc.
|
13,982 | $760,760 |
All Filings in REGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,187,071 | 6,715 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,911,672 | 6,357 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,232,163 | 5,483 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $578,013 | 1,028 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $528,675 | 1,007 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $566,367 | 893 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,287,291 | 3,211 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,974,738 | 3,781 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,236,701 | 4,031 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,845,147 | 3,995 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,010,033 | 1,150 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $965,332 | 1,173 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $810,513 | 1,128 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $794,554 | 967 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $599,558 | 831 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $539,385 | 783 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $357,042 | 604 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $216,510 | 310 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $229,873 | 364 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||